Changes

Jump to navigation Jump to search

ICRP Glossary

886 bytes added, 22:10, 24 February 2021
no edit summary
Although the ICRP Glossary is not a dictionary, terms already well covered in the Oxford English Dictionary are not included here unless further explanation is needed to understand the way in which these terms are used in ICRP publications.
The ICRP Glossary shown here comprises some 400 terms. Entries for an additional approximately 400 terms are being prepared, and will be added here in due courseprogressively.
----
*[[Acceptance test]]
*[[Access Controlcontrol]]
*[[Accountability]]
*[[Activity median thermodynamic diameter]]
*[[Acute Exposureexposure]] *Acute radiation sickness (see *[[Acute radiation syndrome]])
*[[Acute radiation syndrome]]
*[[Adventitious]]
*[[Adventitious Sourcesource]]
*[[Aerodynamic diameter ]]
*[[Alpha decay]]
 
*[[α/β ratio]]
*[[Alveolar-interstitial region]]
*[[Area monitoring]]
 
*ARS (see [[Acute radiation syndrome]])
*[[Attributable risk]]
*[[Auger transition]]
*[[Authorised Dischargedischarge]]
*[[Authorization]]
*[[Background dose (rate)]]
*[[Backscatter Factor factor]]
*[[Basal cell]]
*[[Baseline disease rates]]
 
*BAT (see [[Best available techniques]])
*[[Beneficence]]
*[[Benthic]]
*[[Best Available Techniquesavailable techniques]]
*[[Beta-minus decay]]
=== <big><span id="D">D</span></big> ===
 
*DD (see [[Doubling dose)]])
 
*DDREF (see [[Dose and dose-rate effectiveness factor)]])
*[[Decay constant]]
*[[Deterministic effect]]
*Detriment (see [[DetrimentRadiation detriment]])
*[[Detriment-adjusted risk]]
*[[Disposal]]
*[[Disposal Facilityfacility]]
*[[DNA damage signalling]]
*[[Dose and dose-rate effectiveness factor (DDREF)]]
*[[Dose constraint]]
*[[Dose limit]]
*[[Dose Modifying Factormodifying factor]]
*[[Dose per unit intake coefficient]]
*[[Elemental dose]]
 
*ELR (see *[[Excess lifetime risk]])
*[[Emergency]]
*[[Exposure, external or internal]]
*[[Exposure Pathwaypathway]]
*[[Exposure situation]]
*[[Incidence]]
 
*Incidence rate (see [[Incidence]])
*[[Incident]]
*[[Induced genomic instability]]
*[[Informed Consentconsent]]
*[[Inhalability]]
*[[Linear-quadratic dose response]]
 
*LLE (see [[Loss of Life Expectancy]])
*[[Loss of Life Expectancy]]
*[[Low level waste]]
 
*LSS (see [[Life span study]])
*[[Lymphatic system]]
*[[Neurovascular syndrome]]
 
*NHEJ (see [[Non-homologous end joining]])
*[[Nominal risk coefficient]]
*[[Platelet-derived growth factor]]
 
*PLDR (see [[Potentially lethal damage repair]])
*[[Pooled analysis]]
*[[Radiographer]]
*[[Radiological Controlled Areacontrolled area]]
*[[Radiological protection principles]]
*[[Radiosensitivity, cellular]]
 
*RAP (see [[Reference Animal and Plant]])
 
*RBE (see [[Relative biological effectiveness]])
*[[Reactive oxygen species]]
*[[Reference level]]
 
*REID (see [[Risk of exposure-induced death]])
*[[Rehabilitation of living conditions]]
*[[Risk of exposure-induced death]]
 
*ROS (see [[Reactive oxygen species]])
*[[Routine monitoring]]
 
*RR (see [[Relative risk]])
=== <big><span id="S">S</span></big> ===
*[[Severe deterministic injury]]
 
*SLDR (see [[Sublethal damage repair]])
*[[Slow repair]]
*[[Substantial radiation dose level]]
*[[Supervised Areaarea]]
*[[Systemic model]]
*[[Transparency]]
 
*Transport of risk (see [[Transfer of risk]])
*[[Tumour suppressor gene]]
*[[Wisdom]]
 
*w<sub>T</sub> (see [[Tissue weighting factor]])
 
*w<sub>R</sub> (see [[Radiation weighting factor]])
=== <big><span id="X">X</span></big> ===
*[[α/β value]]
 
*α/β ratio (see [[α/β value]])
*[[γH2AX foci]]
<div>

Navigation menu